A link between adolescent nicotine metabolism and smoking topography

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 5, 2009, Pages 1578-1583

  Moolchan, Eric T ^a,b,c   Parzynski, Craig S ^a   Jaszyna Gasior, Maria ^a   Collins, Charles C ^a   Leff, Michelle K ^a   Zimmerman, Debra L ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b Al Kermes Inc   (United States)

^c ALKERMES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3' HYDROXYCOTININE; CARBON MONOXIDE; COTININE; NICOTINE;

ADOLESCENT; AFRICAN AMERICAN; ARTICLE; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG METABOLISM; EUROPEAN AMERICAN; FEMALE; HORMONAL CONTRACEPTION; HUMAN; INTERPUFF INTERVAL; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NICOTINE METABOLISM; PRIORITY JOURNAL; PUFF DURATION; PUFF VELOCITY; PUFF VOLUME; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE;

ADOLESCENT; ADOLESCENT BEHAVIOR; FEMALE; HUMANS; LINEAR MODELS; MALE; NICOTINE; SEX FACTORS; SMOKING;

EID: 66549125429     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0592     Document Type: Article

References (29)

1. Benowitz NL, Pomerleau OF, Pomerleau CS, Jacob P III. Nicotine metabolite ratio as a predictor of cigarette consumption. Nicotine Tob Res 2003;5:621-624 (Pubitemid 37304836)
2. Pianezza ML, Sellers EM, Tyndale RF. Nicotine metabolism defect reduces smoking. Nature 1998;393:750. (Pubitemid 28299478)
3. O'Loughlin J, Paradis G, Kim W, et al. Genetically decreased CYP2A6 and the risk of tobacco dependence:a prospective study of novice smokers. Tob Control 2004;13:422-428 (Pubitemid 39635932)
4. Rao Y, Hoffman E, Zia M, et al. Duplications and defects in the CYP2A6 gene:identificat ion, genotyping, and in vivo effects on smoking. Mol Pharmacol 2000;58:747-755
5. Schoedel KA, Hoffmann EB, Rao Y, Sellers EM, Tyndale RF. Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians. Pharmacogenetics 2004;14:615-626 (Pubitemid 39281816)
6. Audrain-McGovern J, Al Koudsi N, Rodriguez D, et al. The role of CYP2A6 in the emergence of nicotine dependence in adolescents. Pediatrics 2007;119:e264-74. (Pubitemid 46397834)
7. Herning RI, Jones RT, Benowitz NL, Mines AH. How a cigarette is smoked determines blood nicotine levels. Clin Pharmacol Ther 1983;33:84-90.
8. Rieben FW. Smoking behaviour and increase in nicotine and carboxyhaemoglobin in venous blood. Clin Invest 1992;70:335-342
9. Strasser AA, Malaiyandi V, Hoffmann E, Tyndale RF, Lerman C. An association of CYP2A6 genotype and smoking topography. Nicotine Tob Res 2007;9:511-518 (Pubitemid 46534464)
10. Strasser AA, Pickworth WB, Patterson F, Lerman C. Smoking topography predicts abstinence following treatment with nicotine replacement therapy. Cancer Epidemiol Biomarkers Prev 2004;13:1800-1804 (Pubitemid 39482959)
11. Clark KD, Wardrobe-Wong N, Elliott JJ, Gill PT, Tait NP, Snashall PD. Cigarette smoke inhalation and lung damage in smoking volunteers. Eur Respir J 1998;12:395-399 (Pubitemid 28389535)
12. Garfinkel L, Stellman SD. Smoking and lung cancer in women: findings in a prospective study. Cancer Res 1988;48:6951-6955 (Pubitemid 19012232)
13. Moolchan ET, Ernst M, Henningfield JE. A review of tobacco smoking in adolescents:treatment implications. J Am Acad Child Adolesc Psychiatry 2000;39:682-693 (Pubitemid 30351218)
14. Franken FH, Pickworth WB, Epstein DH, Moolchan ET. Smoking rates and topography predict adolescent smoking cessation following treatment with nicotine replacement therapy. Cancer Epidemiol Biomarkers Prev 2006;15:154-157
15. McNeill AD, West RJ, Jarvis M, Jackson P, Bryant A. Cigarette withdrawal symptoms in adolescent smokers. Psychopharmacology (Berl) 1986;90:533-536 (Pubitemid 17096785)
16. Eissenberg T, Adams C, Riggins EC III, Likness M. Smokers' sex and the effects of tobacco cigarettes:subject-rated and physiological measures. Nicotine Tob Res 1999;1:317-324
17. Wood T, Wewers ME, Groner J, Ahijevych K. Smoke constituent exposure and smoking topography of adolescent daily cigarette smokers. Nicotine Tob Res 2004;6:853-862 (Pubitemid 39504460)
18. Berlin I, Gasior MJ, Moolchan ET. Sex-based and hormonal contraception effects on the metabolism of nicotine among adolescent tobacco-dependent smokers. Nicotine Tob Res 2007;9:493-498 (Pubitemid 46534461)
19. Benowitz NL, Lessov-Schlaggar CN, Swan GE, Jacob P III. Female sex and oral contraceptive use accelerate nicotine metabolism. Clin Pharmacol Ther 2006;9:480-488
20. Moolchan ET, Franken FH, Jaszyna-Gasior M. Adolescent nicotine metabolism:ethnoraci al differences among dependent smokers. Ethn Dis 2006;16:239-243 (Pubitemid 46959274)
21. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom test for nicotine dependence:a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991;86:1119-1127
22. Teeuwen HW, Aalders RJ, Van Rossum JM. Simultaneous estimation of nicotine and cotinine levels in biological fluids using highresolution capillary-column gas chromatography combined with solid phase extraction work-up. Mol Biol Rep 1988;13:165-175
23. Feyerabend C, Russell MA. A rapid gas-liquid chromatographic method for the determination of cotinine and nicotine in biological fluids. J Pharm Pharmacol 1990;42:450-452 (Pubitemid 20313701)
24. Jacob P III, Shulgin AT, Yu L, Benowitz NL. Determination of the nicotine metabolite trans-3′-hydroxycotinine in urine of smokers using gas chromatography with nitrogen-selective detection or selected ion monitoring. J Chromatogr 1992;583:145-154
25. Aung AT, Pickworth WB, Moolchan ET. History of marijuana use and tobacco smoking topography in tobacco-dependent adolescents. Addict Behav 2004;29:699-706. (Pubitemid 38591576)
26. Zimmerman DM, Sehnert SS, Epstein DH, Pickworth WB, Robinson ML, Moolchan ET. Smoking topography and trajectory of asthmatic adolescents requesting cessation treatment. Prev Med 2004;39:940-942 (Pubitemid 39314462)
27. Benowitz NL, Perez-Stable EJ, Fong I, Modin G, Herrera B, Jacob P III. Ethnic differences in N-glucuronidation of nicotine and cotinine. J Pharmacol Exp Ther 1999;1:1196-1203
28. Woodman G, Newman SP, Pavia D, Clarke SW. Inhaled smoke volume and puff indices with cigarettes of different tar and nicotine levels. Eur J Respir Dis 1987;70:187-192 (Pubitemid 17029524)
29. Naqvi NH, Bechara A. The airway sensory impact of nicotine contributes to the conditioned reinforcing effects of individual puffs from cigarettes. Pharmacol Biochem Behav 2005;81:821-829 (Pubitemid 41187815)